Free Trial

Ares Capital (ARCC) to Release Earnings on Tuesday

Ares Capital logo with Finance background

Ares Capital (NASDAQ:ARCC - Get Free Report) is projected to announce its Q2 2025 earnings results before the market opens on Tuesday, July 29th. Analysts expect the company to announce earnings of $0.51 per share and revenue of $748.76 million for the quarter.

Ares Capital (NASDAQ:ARCC - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The investment management company reported $0.50 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.04). The business had revenue of $599.00 million during the quarter, compared to analyst estimates of $769.32 million. Ares Capital had a net margin of 43.50% and a return on equity of 11.05%. The company's revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.59 earnings per share. On average, analysts expect Ares Capital to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ares Capital Trading Up 0.0%

ARCC traded up $0.01 during trading on Friday, hitting $23.04. The company's stock had a trading volume of 712,991 shares, compared to its average volume of 4,596,015. The firm's 50 day moving average price is $22.14 and its 200-day moving average price is $22.03. The company has a debt-to-equity ratio of 1.02, a current ratio of 1.40 and a quick ratio of 1.40. The stock has a market cap of $15.99 billion, a PE ratio of 11.24 and a beta of 0.67. Ares Capital has a twelve month low of $18.26 and a twelve month high of $23.84.

Ares Capital Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Friday, June 13th were issued a $0.48 dividend. The ex-dividend date of this dividend was Friday, June 13th. This represents a $1.92 annualized dividend and a yield of 8.34%. Ares Capital's dividend payout ratio (DPR) is presently 93.66%.

Analyst Ratings Changes

Several brokerages have weighed in on ARCC. Keefe, Bruyette & Woods cut their price target on Ares Capital from $23.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 8th. B. Riley upgraded Ares Capital to a "hold" rating in a report on Monday, June 16th. Wells Fargo & Company upped their price objective on Ares Capital from $21.00 to $22.00 and gave the stock an "overweight" rating in a report on Friday, June 27th. Royal Bank Of Canada decreased their price target on shares of Ares Capital from $24.00 to $23.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Ares Capital from $24.50 to $22.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $22.21.

Check Out Our Latest Stock Analysis on Ares Capital

Hedge Funds Weigh In On Ares Capital

Several institutional investors have recently bought and sold shares of ARCC. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Ares Capital in the first quarter worth about $273,000. AQR Capital Management LLC raised its position in shares of Ares Capital by 6.5% in the first quarter. AQR Capital Management LLC now owns 16,502 shares of the investment management company's stock valued at $365,000 after purchasing an additional 1,000 shares during the period. Empowered Funds LLC raised its position in shares of Ares Capital by 139.9% in the first quarter. Empowered Funds LLC now owns 27,655 shares of the investment management company's stock valued at $613,000 after purchasing an additional 16,128 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC bought a new position in shares of Ares Capital in the first quarter valued at approximately $14,766,000. Finally, Goldman Sachs Group Inc. raised its holdings in Ares Capital by 14.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,835,007 shares of the investment management company's stock worth $62,824,000 after acquiring an additional 358,829 shares during the period. 27.38% of the stock is currently owned by institutional investors.

Ares Capital Company Profile

(Get Free Report)

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.

Read More

Earnings History for Ares Capital (NASDAQ:ARCC)

Should You Invest $1,000 in Ares Capital Right Now?

Before you consider Ares Capital, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ares Capital wasn't on the list.

While Ares Capital currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines